Celldex cancer drug crashes out at Phase 2b

21:42 EDT 16 Apr 2018 | BioPharmaDive

The biotech will ditch further development after the drug failed to meet its primary endpoint in a triple-negative breast cancer study.

Original Article: Celldex cancer drug crashes out at Phase 2b


More From BioPortfolio on "Celldex cancer drug crashes out at Phase 2b"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...